Concord Biotech Ltd. - Research Center
543960 CONCORDBIO Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Dec' 22 |
Sales |
318.97 |
240.80 |
262.35 |
194.83 |
240.68 |
Operating profit |
134.29 |
105.93 |
119.19 |
72.15 |
111.68 |
Interest |
0.46 |
0.50 |
0.84 |
0.75 |
0.91 |
Gross profit |
144.64 |
113.62 |
126.47 |
78.05 |
120.02 |
EPS (Rs) |
9.29 |
7.13 |
8.08 |
4.63 |
7.56 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Dec' 22 |
Other income |
10.81 |
8.19 |
8.13 |
6.65 |
9.25 |
Stock adjustment |
21.73 |
-23.52 |
0.39 |
-10.67 |
-1.47 |
Raw material |
55.67 |
47.39 |
42.00 |
39.48 |
43.36 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
33.96 |
30.67 |
30.17 |
28.25 |
27.54 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
73.33 |
80.33 |
70.60 |
65.62 |
59.57 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
13.72 |
13.54 |
13.30 |
13.04 |
13.77 |
Taxation |
33.70 |
25.53 |
28.68 |
16.54 |
27.17 |
Net profit / loss |
97.21 |
74.55 |
84.49 |
48.47 |
79.08 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.46 |
10.46 |
10.46 |
10.46 |
10.46 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
42.10 |
43.99 |
45.43 |
37.03 |
46.40 |
GPM (%) |
43.86 |
45.63 |
46.76 |
38.74 |
48.02 |
NPM (%) |
29.48 |
29.94 |
31.24 |
24.06 |
31.64 |